SunRegen is a biopharmaceutical company with a mission to develop drugs to treat neurodegenerative diseases.
Products, services, technology
SunRegen is focusing on innovative treatments for patients suffering from neurological, neuromuscular and ophthalmic diseases. Our first product candidates in development target ophthalmic disease. We further evaluate them for use in serious neurological / neuromuscular diseases
SunRegen is open to collaborate with academia and industrial partners.